1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by OTC Pet Medication Revenue
• 1.4 Market by Type
  • 1.4.1 Global OTC Pet Medication Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Fleas & Ticks Removal
  • 1.4.3 Pain Relief & Arthritis
  • 1.4.4 Dewormers
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global OTC Pet Medication Market Share by Application: 2020 VS 2026
  • 1.5.2 Dogs & Cats
  • 1.5.3 Birds
  • 1.5.4 Fish & Reptiles
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global OTC Pet Medication Market Perspective (2015-2026)
• 2.2 Global OTC Pet Medication Growth Trends by Regions
  • 2.2.1 OTC Pet Medication Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 OTC Pet Medication Historic Market Share by Regions (2015-2020)
  • 2.2.3 OTC Pet Medication Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 OTC Pet Medication Market Growth Strategy
  • 2.3.6 Primary Interviews with Key OTC Pet Medication Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top OTC Pet Medication Players by Market Size
  • 3.1.1 Global Top OTC Pet Medication Players by Revenue (2015-2020)
  • 3.1.2 Global OTC Pet Medication Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global OTC Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global OTC Pet Medication Market Concentration Ratio
  • 3.2.1 Global OTC Pet Medication Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by OTC Pet Medication Revenue in 2019
• 3.3 OTC Pet Medication Key Players Head office and Area Served
• 3.4 Key Players OTC Pet Medication Product Solution and Service
• 3.5 Date of Enter into OTC Pet Medication Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global OTC Pet Medication Historic Market Size by Type (2015-2020)
• 4.2 Global OTC Pet Medication Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global OTC Pet Medication Market Size by Application (2015-2020)
• 5.2 Global OTC Pet Medication Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America OTC Pet Medication Market Size (2015-2020)
• 6.2 OTC Pet Medication Key Players in North America (2019-2020)
• 6.3 North America OTC Pet Medication Market Size by Type (2015-2020)
• 6.4 North America OTC Pet Medication Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe OTC Pet Medication Market Size (2015-2020)
• 7.2 OTC Pet Medication Key Players in Europe (2019-2020)
• 7.3 Europe OTC Pet Medication Market Size by Type (2015-2020)
• 7.4 Europe OTC Pet Medication Market Size by Application (2015-2020)

8 China

• 8.1 China OTC Pet Medication Market Size (2015-2020)
• 8.2 OTC Pet Medication Key Players in China (2019-2020)
• 8.3 China OTC Pet Medication Market Size by Type (2015-2020)
• 8.4 China OTC Pet Medication Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan OTC Pet Medication Market Size (2015-2020)
• 9.2 OTC Pet Medication Key Players in Japan (2019-2020)
• 9.3 Japan OTC Pet Medication Market Size by Type (2015-2020)
• 9.4 Japan OTC Pet Medication Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia OTC Pet Medication Market Size (2015-2020)
• 10.2 OTC Pet Medication Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia OTC Pet Medication Market Size by Type (2015-2020)
• 10.4 Southeast Asia OTC Pet Medication Market Size by Application (2015-2020)

11 India

• 11.1 India OTC Pet Medication Market Size (2015-2020)
• 11.2 OTC Pet Medication Key Players in India (2019-2020)
• 11.3 India OTC Pet Medication Market Size by Type (2015-2020)
• 11.4 India OTC Pet Medication Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America OTC Pet Medication Market Size (2015-2020)
• 12.2 OTC Pet Medication Key Players in Central & South America (2019-2020)
• 12.3 Central & South America OTC Pet Medication Market Size by Type (2015-2020)
• 12.4 Central & South America OTC Pet Medication Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Bayer Companion Animal
  • 13.1.1 Bayer Companion Animal Company Details
  • 13.1.2 Bayer Companion Animal Business Overview
  • 13.1.3 Bayer Companion Animal OTC Pet Medication Introduction
  • 13.1.4 Bayer Companion Animal Revenue in OTC Pet Medication Business (2015-2020))
  • 13.1.5 Bayer Companion Animal Recent Development
• 13.2 Boehringer Ingelheim Animal Health
  • 13.2.1 Boehringer Ingelheim Animal Health Company Details
  • 13.2.2 Boehringer Ingelheim Animal Health Business Overview
  • 13.2.3 Boehringer Ingelheim Animal Health OTC Pet Medication Introduction
  • 13.2.4 Boehringer Ingelheim Animal Health Revenue in OTC Pet Medication Business (2015-2020)
  • 13.2.5 Boehringer Ingelheim Animal Health Recent Development
• 13.3 Ceva Sante Animale
  • 13.3.1 Ceva Sante Animale Company Details
  • 13.3.2 Ceva Sante Animale Business Overview
  • 13.3.3 Ceva Sante Animale OTC Pet Medication Introduction
  • 13.3.4 Ceva Sante Animale Revenue in OTC Pet Medication Business (2015-2020)
  • 13.3.5 Ceva Sante Animale Recent Development
• 13.4 Merck Inc.
  • 13.4.1 Merck Inc. Company Details
  • 13.4.2 Merck Inc. Business Overview
  • 13.4.3 Merck Inc. OTC Pet Medication Introduction
  • 13.4.4 Merck Inc. Revenue in OTC Pet Medication Business (2015-2020)
  • 13.4.5 Merck Inc. Recent Development
• 13.5 Zoetis Inc.
  • 13.5.1 Zoetis Inc. Company Details
  • 13.5.2 Zoetis Inc. Business Overview
  • 13.5.3 Zoetis Inc. OTC Pet Medication Introduction
  • 13.5.4 Zoetis Inc. Revenue in OTC Pet Medication Business (2015-2020)
  • 13.5.5 Zoetis Inc. Recent Development
• 13.6 Elanco
  • 13.6.1 Elanco Company Details
  • 13.6.2 Elanco Business Overview
  • 13.6.3 Elanco OTC Pet Medication Introduction
  • 13.6.4 Elanco Revenue in OTC Pet Medication Business (2015-2020)
  • 13.6.5 Elanco Recent Development
• 13.7 Virbac SA
  • 13.7.1 Virbac SA Company Details
  • 13.7.2 Virbac SA Business Overview
  • 13.7.3 Virbac SA OTC Pet Medication Introduction
  • 13.7.4 Virbac SA Revenue in OTC Pet Medication Business (2015-2020)
  • 13.7.5 Virbac SA Recent Development
• 13.8 Vetoquinol SA
  • 13.8.1 Vetoquinol SA Company Details
  • 13.8.2 Vetoquinol SA Business Overview
  • 13.8.3 Vetoquinol SA OTC Pet Medication Introduction
  • 13.8.4 Vetoquinol SA Revenue in OTC Pet Medication Business (2015-2020)
  • 13.8.5 Vetoquinol SA Recent Development
• 13.9 Frontline
  • 13.9.1 Frontline Company Details
  • 13.9.2 Frontline Business Overview
  • 13.9.3 Frontline OTC Pet Medication Introduction
  • 13.9.4 Frontline Revenue in OTC Pet Medication Business (2015-2020)
  • 13.9.5 Frontline Recent Development
• 13.10 Zymox
  • 13.10.1 Zymox Company Details
  • 13.10.2 Zymox Business Overview
  • 13.10.3 Zymox OTC Pet Medication Introduction
  • 13.10.4 Zymox Revenue in OTC Pet Medication Business (2015-2020)
  • 13.10.5 Zymox Recent Development
• 13.11 ChloraSeb
  • 10.11.1 ChloraSeb Company Details
  • 10.11.2 ChloraSeb Business Overview
  • 10.11.3 ChloraSeb OTC Pet Medication Introduction
  • 10.11.4 ChloraSeb Revenue in OTC Pet Medication Business (2015-2020)
  • 10.11.5 ChloraSeb Recent Development
• 13.12 Sulfox
  • 10.12.1 Sulfox Company Details
  • 10.12.2 Sulfox Business Overview
  • 10.12.3 Sulfox OTC Pet Medication Introduction
  • 10.12.4 Sulfox Revenue in OTC Pet Medication Business (2015-2020)
  • 10.12.5 Sulfox Recent Development
• 13.13 Adequan
  • 10.13.1 Adequan Company Details
  • 10.13.2 Adequan Business Overview
  • 10.13.3 Adequan OTC Pet Medication Introduction
  • 10.13.4 Adequan Revenue in OTC Pet Medication Business (2015-2020)
  • 10.13.5 Adequan Recent Development
• 13.14 Dechra Pharmaceuticals PLC
  • 10.14.1 Dechra Pharmaceuticals PLC Company Details
  • 10.14.2 Dechra Pharmaceuticals PLC Business Overview
  • 10.14.3 Dechra Pharmaceuticals PLC OTC Pet Medication Introduction
  • 10.14.4 Dechra Pharmaceuticals PLC Revenue in OTC Pet Medication Business (2015-2020)
  • 10.14.5 Dechra Pharmaceuticals PLC Recent Development
• 13.15 Nutramax Laboratories, Inc.
  • 10.15.1 Nutramax Laboratories, Inc. Company Details
  • 10.15.2 Nutramax Laboratories, Inc. Business Overview
  • 10.15.3 Nutramax Laboratories, Inc. OTC Pet Medication Introduction
  • 10.15.4 Nutramax Laboratories, Inc. Revenue in OTC Pet Medication Business (2015-2020)
  • 10.15.5 Nutramax Laboratories, Inc. Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

OTC Pet Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global OTC Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bayer Companion Animal
Boehringer Ingelheim Animal Health
Ceva Sante Animale
Merck Inc.
Zoetis Inc.
Elanco
Virbac SA
Vetoquinol SA
Frontline
Zymox
ChloraSeb
Sulfox
Adequan
Dechra Pharmaceuticals PLC
Nutramax Laboratories, Inc.

Market segment by Type, the product can be split into
Fleas & Ticks Removal
Pain Relief & Arthritis
Dewormers
Others
Market segment by Application, split into
Dogs & Cats
Birds
Fish & Reptiles
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America